Testing a new anxiety medication for safety
Treatments studied
Part of Mental health clinical trials.
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a body mass index (BMI) between 19 and 40.
- You must have been diagnosed with moderate or severe generalized anxiety disorder.
- You must be able to attend all study visits and follow the study instructions.
- You must be willing to use effective birth control if you are able to have children.
- You must not be pregnant or breastfeeding.
- You must not have a history of schizophrenia, bipolar disorder, or other psychotic disorders.
- You must not have had recent suicidal thoughts or behaviors.
- If you are joining from a previous study, you must have completed it safely and be willing to continue your current anxiety medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication (ITI-1284) added to your current anxiety treatment to see if it improves symptoms. It's for adults with generalized anxiety disorder (GAD) who haven't gotten enough relief from their current medicine.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests an investigational oral medication (ITI-1284) for people with moderate to severe generalized anxiety disorder (GAD) who haven't found enough relief from at least two standard medications. The goal is to see if this new drug helps reduce anxiety symptoms.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medication, JNJ-99245354 (also called ITI-1284), added to your current anxiety treatment to see if it helps reduce anxiety symptoms. You may be eligible if you've already tried at least one FDA-approved treatment for generalized anxiety disorder without enough improvement.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.